ALEC - Alector, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$2.25
DETAILS
HIGH:
$3.00
LOW:
$1.50
MEDIAN:
$2.25
CONSENSUS:
$2.25
UPSIDE:
20.32%
About Alector, Inc. (https://www.alector.com)
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Arnon Rosenthal | Co-Founder, Chief Executive Officer & Director | 1956 | $1,013,926 USD |
| Neil Berkley | CFO & Chief Business Officer | 1974 | $705,122 USD |
| Caiyan Li | Head of Clinical Development & Data Science | – | – |
| Clare Hunt | Chief People & Places Officer | – | – |
| Danielle Pasqualone | General Counsel | – | – |
| Eric Brown | Director of Antibody Discovery & Protein Engineering | – | – |
| Hua Long DABT | Senior VP & Head of Research | – | – |
| Katie Hogan | Senior Director of Corporate Communication & Investor Relations | – | – |